These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1934187

  • 21. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K, Takizawa T, Yuda T, Kennel SJ, Huang L, Iwatsuru M.
    Biochim Biophys Acta; 1995 Mar 08; 1234(1):74-80. PubMed ID: 7880861
    [Abstract] [Full Text] [Related]

  • 22. Molecular localization and state of amphotericin B in PEG liposomes.
    Moribe K, Maruyama K, Iwatsuru M.
    Int J Pharm; 1999 Dec 20; 193(1):97-106. PubMed ID: 10581426
    [Abstract] [Full Text] [Related]

  • 23. Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes.
    Unezaki S, Maruyama K, Ishida O, Takahashi N, Iwatsuru M.
    J Drug Target; 1993 Dec 20; 1(4):287-92. PubMed ID: 8069570
    [Abstract] [Full Text] [Related]

  • 24. Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes.
    Moribe K, Maruyama K, Iwatsuru M.
    Int J Pharm; 2000 May 15; 201(1):37-49. PubMed ID: 10867263
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of Uncleavable and Cleavable PEG-Lipids with Different Molecular Weights on Accelerated Blood Clearance of PEGylated Emulsions in Beagle Dogs.
    Jiao J, Luo X, Wang C, Jiao X, Liu M, Liu X, Wei L, Deng Y, Song Y.
    AAPS PharmSciTech; 2020 Mar 17; 21(3):106. PubMed ID: 32185548
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats.
    Takeuchi H, Kojima H, Yamamoto H, Kawashima Y.
    J Control Release; 2001 Jul 10; 75(1-2):83-91. PubMed ID: 11451499
    [Abstract] [Full Text] [Related]

  • 32. In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography.
    Oku N, Tokudome Y, Tsukada H, Kosugi T, Namba Y, Okada S.
    Biopharm Drug Dispos; 1996 Jul 10; 17(5):435-41. PubMed ID: 8830978
    [Abstract] [Full Text] [Related]

  • 33. [Effect of membrane modification by PEG on prolongation of circulation time of liposomes in blood in vivo].
    Hou XP, Zhang JM, Lu XD.
    Yao Xue Xue Bao; 1996 Jul 10; 31(6):451-4. PubMed ID: 9275724
    [Abstract] [Full Text] [Related]

  • 34. Effect of gangliosides on structure and integrity of polyethylene glycol (PEG)-stabilized liposomes.
    Grad P, Gedda L, Edwards K.
    J Colloid Interface Sci; 2020 Oct 15; 578():281-289. PubMed ID: 32531558
    [Abstract] [Full Text] [Related]

  • 35. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen.
    Litzinger DC, Huang L.
    Biochim Biophys Acta; 1992 Aug 19; 1127(3):249-54. PubMed ID: 1511002
    [Abstract] [Full Text] [Related]

  • 36. Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties.
    Ho EA, Ramsay E, Ginj M, Anantha M, Bregman I, Sy J, Woo J, Osooly-Talesh M, Yapp DT, Bally MB.
    J Pharm Sci; 2010 Jun 19; 99(6):2839-53. PubMed ID: 20091826
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
    Allen TM, Hansen C.
    Biochim Biophys Acta; 1991 Sep 30; 1068(2):133-41. PubMed ID: 1911826
    [Abstract] [Full Text] [Related]

  • 38. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M, Malhotra A, Anantha M, Roosendaal J, Leung AWY, Plackett D, Edwards K, Gilabert-Oriol R, Bally MB.
    J Control Release; 2017 Apr 28; 252():50-61. PubMed ID: 28286316
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS, Nawata K, Shimizu T, Ishida T, Kiwada H.
    Int J Pharm; 2013 Nov 01; 456(1):235-42. PubMed ID: 23928149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.